Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder, in healthy Japanese male subjects: results from single- and multiple-dose studies.
Iitsuka H, Tokuno T, Amada Y, Matsushima H, Katashima M, Sawamoto T, Takusagawa S, van Gelderen M, Tanaka T, Miyahara H. Iitsuka H, et al. Clin Drug Investig. 2014 Jan;34(1):27-35. doi: 10.1007/s40261-013-0146-1. Clin Drug Investig. 2014. PMID: 24178236 Free PMC article. Clinical Trial.
Single dose pharmacokinetics and absolute bioavailability of mirabegron, a β₃-adrenoceptor agonist for treatment of overactive bladder.
Eltink C, Lee J, Schaddelee M, Zhang W, Kerbusch V, Meijer J, van Marle S, Grunenberg N, Kowalski D, Drogendijk T, Moy S, Iitsuka H, van Gelderen M, Matsushima H, Sawamoto T. Eltink C, et al. Among authors: iitsuka h. Int J Clin Pharmacol Ther. 2012 Nov;50(11):838-50. doi: 10.5414/CP201782. Int J Clin Pharmacol Ther. 2012. PMID: 22943933 Clinical Trial.
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652, a Reversible Fatty Acid Amide Hydrolase Inhibitor, in Healthy, Nonelderly, Japanese Men and Elderly, Japanese Men and Women: A Randomized, Double-blind, Placebo-controlled, Single and Multiple Oral Dose, Phase I Study.
Takizawa M, Hatta T, Iitsuka H, Katashima M, Sato Y, Kuroishi K, Nagashima H. Takizawa M, et al. Among authors: iitsuka h. Clin Ther. 2020 May;42(5):906-923. doi: 10.1016/j.clinthera.2020.03.021. Epub 2020 May 23. Clin Ther. 2020. PMID: 32456804 Clinical Trial.
[Amaurosis fugax in Marfan syndrome with myxomatous degeneration].
Sato T, Satake M, Iitsuka H, Mimori M, Umehara T, Takeuchi C, Iguchi Y. Sato T, et al. Among authors: iitsuka h. Rinsho Shinkeigaku. 2024 Oct 29;64(10):719-724. doi: 10.5692/clinicalneurol.cn-001987. Epub 2024 Oct 21. Rinsho Shinkeigaku. 2024. PMID: 39313367 Japanese.
Discovery of a sugar-based nanoparticle universally existing in boiling herbal water extracts and their immunostimulant effect.
Iitsuka H, Koizumi K, Inujima A, Suzaki M, Mizuno Y, Takeshita Y, Eto T, Otsuka Y, Shimada R, Liu M, Ikeda K, Nakano M, Suzuki R, Maruyama K, Zhou Y, Sakurai H, Shibahara N. Iitsuka H, et al. Biochem Biophys Rep. 2018 Oct 11;16:62-68. doi: 10.1016/j.bbrep.2018.08.004. eCollection 2018 Dec. Biochem Biophys Rep. 2018. PMID: 30338298 Free PMC article.
12 results